ORAL PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERATION OF MESALAZINE.

摘要

Oral controlled release pharmaceutical compositions containing as active ingredient 5-aminosalicylic acid, comprising: a) an internal lipophilic matrix consisting of substances with a melting point below 90 ° C in which the active ingredient is at least partially encompassed; b) an external hydrophilic matrix in which the lipophilic matrix is dispersed; c) optionally other excipients.